Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

In vivo differentiated human embryonic stem cells can acquire chromosomal aberrations more frequently than in vitro during the same period.

Zucchelli M, Ström S, Holm F, Malmgren H, Sahlén S, Religa P, Hovatta O, Kere J, Inzunza J.

Stem Cells Dev. 2012 Dec 10;21(18):3363-71. doi: 10.1089/scd.2012.0066.

PMID:
22709429
2.

Human embryonic stem cells as models for aneuploid chromosomal syndromes.

Biancotti JC, Narwani K, Buehler N, Mandefro B, Golan-Lev T, Yanuka O, Clark A, Hill D, Benvenisty N, Lavon N.

Stem Cells. 2010 Sep;28(9):1530-40. doi: 10.1002/stem.483.

3.

The tumorigenicity of diploid and aneuploid human pluripotent stem cells.

Blum B, Benvenisty N.

Cell Cycle. 2009 Dec;8(23):3822-30. Review.

PMID:
19887907
4.

Effect of chromosome instability on the maintenance and differentiation of human embryonic stem cells in vitro and in vivo.

Moon SH, Kim JS, Park SJ, Lim JJ, Lee HJ, Lee SM, Chung HM.

Stem Cell Res. 2011 Jan;6(1):50-9. doi: 10.1016/j.scr.2010.08.006.

5.

Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically.

Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K.

Hum Reprod. 2009 Oct;24(10):2477-89. doi: 10.1093/humrep/dep234.

PMID:
19584135
6.

Triploid and diploid embryonic stem cell lines derived from tripronuclear human zygotes.

Chen X, Luo Y, Fan Y, Yue L, Wu X, Chen Y, Sun X.

J Assist Reprod Genet. 2012 Aug;29(8):713-21. doi: 10.1007/s10815-012-9764-4.

7.

Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.

Baker DE, Harrison NJ, Maltby E, Smith K, Moore HD, Shaw PJ, Heath PR, Holden H, Andrews PW.

Nat Biotechnol. 2007 Feb;25(2):207-15.

PMID:
17287758
8.

Chromosome dynamic changes in two cultured Chinese human embryonic stem cell lines: single nucleotide polymorphism, copy number variation and loss of heterozygosity.

Chen XM, Kan QC, Wang F, Kong HJ, Zhang YY, Yu WZ, Sun YP.

J Cell Biochem. 2012 Nov;113(11):3520-7. doi: 10.1002/jcb.24229.

PMID:
22711576
9.

A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.

Hovatta O, Jaconi M, Töhönen V, Béna F, Gimelli S, Bosman A, Holm F, Wyder S, Zdobnov EM, Irion O, Andrews PW, Antonarakis SE, Zucchelli M, Kere J, Feki A.

PLoS One. 2010 Apr 23;5(4):e10263. doi: 10.1371/journal.pone.0010263.

10.

Separation and maintenance of normal cells from human embryonic stem cells with trisomy 12 mosaicism.

Seol HW, Oh SK, Park YB, Kim HS, Baek JA, Seo J, Kim EH, Ku SY, Kim SH, Choi YM, Moon SY.

Chromosome Res. 2008;16(8):1075-84. doi: 10.1007/s10577-008-1258-y.

PMID:
18937039
11.

Chromosome 7 and 19 trisomy in cultured human neural progenitor cells.

Sareen D, McMillan E, Ebert AD, Shelley BC, Johnson JA, Meisner LF, Svendsen CN.

PLoS One. 2009 Oct 29;4(10):e7630. doi: 10.1371/journal.pone.0007630.

12.

In vitro culture conditions favoring selection of chromosomal abnormalities in human ES cells.

Imreh MP, Gertow K, Cedervall J, Unger C, Holmberg K, Szöke K, Csöregh L, Fried G, Dilber S, Blennow E, Ahrlund-Richter L.

J Cell Biochem. 2006 Oct 1;99(2):508-16.

PMID:
16622834
13.

Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q.

Dekel-Naftali M, Aviram-Goldring A, Litmanovitch T, Shamash J, Reznik-Wolf H, Laevsky I, Amit M, Itskovitz-Eldor J, Yung Y, Hourvitz A, Schiff E, Rienstein S.

Eur J Hum Genet. 2012 Dec;20(12):1248-55. doi: 10.1038/ejhg.2012.128.

14.

Derivation of euploid human embryonic stem cells from aneuploid embryos.

Lavon N, Narwani K, Golan-Lev T, Buehler N, Hill D, Benvenisty N.

Stem Cells. 2008 Jul;26(7):1874-82. doi: 10.1634/stemcells.2008-0156.

15.

Enrichment and purging of human embryonic stem cells by detection of cell surface antigens using the monoclonal antibodies TG30 and GCTM-2.

Polanco JC, Wang B, Zhou Q, Chy H, O'Brien C, Laslett AL.

J Vis Exp. 2013 Dec 6;(82):50856. doi: 10.3791/50856.

16.

Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture.

Caisander G, Park H, Frej K, Lindqvist J, Bergh C, Lundin K, Hanson C.

Chromosome Res. 2006;14(2):131-7.

PMID:
16544187
17.

Characterization and gene expression profiling of five human embryonic stem cell lines derived in Taiwan.

Li SS.

Methods Mol Biol. 2012;873:127-49. doi: 10.1007/978-1-61779-794-1_8.

PMID:
22528352
18.

Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?

Catalina P, Montes R, Ligero G, Sanchez L, de la Cueva T, Bueno C, Leone PE, Menendez P.

Mol Cancer. 2008 Oct 3;7:76. doi: 10.1186/1476-4598-7-76.

19.

Studying early lethality of 45,XO (Turner's syndrome) embryos using human embryonic stem cells.

Urbach A, Benvenisty N.

PLoS One. 2009;4(1):e4175. doi: 10.1371/journal.pone.0004175.

20.

Establishment, characterization, and differentiation of a karyotypically normal human embryonic stem cell line from a trisomy-affected embryo.

Mandal A, Mathew S, Saha D, Viswanathan C.

In Vitro Cell Dev Biol Anim. 2013 Jan;49(1):15-26. doi: 10.1007/s11626-012-9567-z.

PMID:
23242925

Supplemental Content

Support Center